Expert Review Of Clinical Immunology

Expert Review Of Clinical Immunology英文简介

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.

Articles focus on the following key areas:

? Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines

? Performance and benefits of newly approved therapeutic agents

? New diagnostic approaches

? Screening and patient stratification

? Pharmacoeconomic studies

? New therapeutic indications for existing therapies

? Adverse effects, occurrence and reduction

? Prospects for medicines in late-stage trials approaching regulatory approval

? Novel treatment strategies

? Epidemiological studies

? Commentary and comparison of treatment guidelines

Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.

Expert Review Of Clinical Immunology中文简介

《Expert Review Of Clinical Immunology》是一本由TAYLOR & FRANCIS LTD出版商出版的专业医学期刊，该刊创刊于2005年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：免疫学 3区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖免疫学等领域，旨在及时、准确、全面地报道国内外免疫学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为5.124，平均审稿速度较慢,6-12周。

中科院分区最新升级版（当前数据版本：2021年12月最新升级版）

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	IMMUNOLOGY 免疫学	3区	否	是

中科院分区最新基础版（当前数据版本：2021年12月最新基础版）

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	IMMUNOLOGY 免疫学	3区	否	是

中科院JCR分区历年趋势图

JCR分区（当前数据版本：2021-2022年最新版）

JCR分区等级	JCR所属学科	分区	影响因子
Q2	IMMUNOLOGY	Q2	5.124

期刊指数

影响因子	h-index	Gold OA文章占比	研究类文章占比	OA开放访问	平均审稿速度
5.124	42	7.17%	27.88%	未开放	较慢,6-12周

IF值(影响因子)趋势图